Meropenem Kabi

Meropenem, the active ingredient in Meropenem Kabi, is a carbapenem antibiotic presented as a sterile powder for reconstitution for intravenous use. It treats serious bacterial infections such as intra‑abdominal infections, hospital‑acquired pneumonia, and sepsis in hospitalized patients. It provides broad‑spectrum coverage against Gram‑negative, Gram‑positive and anaerobic organisms and is indicated for use in critically ill patients, including those in intensive care units.

GNH USA supplies Meropenem Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a carbapenem antibiotic used to treat severe bacterial infections across several organ systems.

- Complicated intra‑abdominal infections: provides broad‑spectrum eradication of Gram‑negative, Gram‑positive and anaerobic pathogens. - Hospital‑acquired pneumonia: achieves rapid bacterial clearance in nosocomial lung infections. - Ventilator‑associated pneumonia: offers effective therapy for ventilated patients with resistant organisms. - Complicated urinary tract infections: clears infections caused by multidrug‑resistant uropathogens. - Sepsis and septic shock: contributes to control of systemic infection in critically ill patients.

Adverse reactions may occur with any antimicrobial therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: often self‑limited, may be watery. - Rash: erythematous skin eruption, sometimes pruritic. - Injection site phlebitis: pain or redness at IV site.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or high doses. - Anaphylaxis: severe allergic reaction with hypotension and airway compromise. - Clostridioides difficile‑associated diarrhea: colitis that can be life‑threatening. - Hematologic abnormalities: neutropenia, thrombocytopenia, or anemia.

Use meropenem with careful clinical monitoring.

- Renal function: adjust dose in patients with impaired renal clearance. - Hypersensitivity: avoid in individuals with known carbapenem or β‑lactam allergy. - Seizure risk: monitor patients with central nervous system disorders or receiving high doses. - Pregnancy and lactation: prescribe only if potential benefit outweighs potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines; review patient medication lists.

Major Interactions (Avoid): - Valproic acid: concurrent use can increase seizure risk. - Probenecid: may reduce renal clearance of meropenem, raising plasma levels. - Cytotoxic chemotherapy: combined use may heighten neurotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Other nephrotoxic agents: watch for additive renal impairment. - Anticonvulsants (e.g., carbamazepine): may lower seizure threshold when used together.